文献速递眼整形与眼眶神经眼科

Graves眼病患者康复性眼眶减压术后突眼复发的术前危险因素

Preoperative Risk Factors for Proptosis Recurrence After Rehabilitative Orbital Decompression in Graves' Orbitopathy Patients.
PubMed 文献 · Am J Ophthalmol · 2023-08-04

这项回顾性病例对照研究纳入2017年1月至2020年12月由同一术者行康复性眼眶减压术的217例非活动期Graves眼病患者,随访3至30个月(平均15.6个月),11例(5.1%)出现突眼复发。单因素分析显示促甲状腺激素受体抗体(TRAb)和甲状腺刺激免疫球蛋白(TSI)与复发显著相关,多因素分析中TRAb仍显著(比值比1.06,P=0.014);TRAb为7.96 IU/L时曲线下面积0.86,灵敏度90.9%,特异度82.0%。作者认为术前TRAb和TSI有助于预测术后突眼复发。

要点

  • 217例Graves眼病眼眶减压术后11例(5.1%)突眼复发,随访平均15.6个月。
  • 术前TRAb与TSI与突眼复发显著相关,多因素分析TRAb比值比1.06(P=0.014)。
  • TRAb 7.96 IU/L时预测复发的曲线下面积0.86,灵敏度90.9%,特异度82.0%。

核心结论

  • 术前TRAb和TSI是预测眼眶减压术后突眼复发的有价值标志物。
  • 这些结果可能帮助术者决定眼眶减压术的最佳时机,以降低术后突眼复发风险。

研究设计与样本

  • 回顾性病例对照研究,纳入2017年1月至2020年12月由同一术者行康复性眼眶减压术的非活动期(临床活动度评分0-2)伴毁容性突眼的Graves眼病患者217例。
  • 突眼用Hertel突眼计测量,复发定义为随访期间减压术后突眼增加2 mm或以上。
  • 采用多因素logistic回归分析术前变量与突眼复发的关联。

主要发现

  • 217例中11例(5.1%)在随访期间(范围3-30个月,平均15.6个月)出现突眼复发。
  • 单因素logistic回归分析显示TRAb和TSI为复发的显著因素,年龄、性别、吸烟、病程、眼眶放疗和甲状腺全切史不显著。
  • 多因素logistic回归分析中TRAb仍显著(比值比1.06,P=0.014)。
  • 受试者工作特征曲线分析显示,TRAb水平为7.96 IU/L时曲线下面积0.86,灵敏度90.9%,特异度82.0%。

关键数值与推荐

  • 复发定义为随访期间减压术后突眼增加2 mm或以上。
  • TRAb预测复发的曲线下面积0.86,截断值7.96 IU/L,灵敏度90.9%,特异度82.0%。

临床怎么用

  • 作者认为术前TRAb和TSI是预测眼眶减压术后突眼复发的有价值标志物。
  • 作者认为这些结果可能帮助术者决定眼眶减压术的最佳时机,以降低术后突眼复发风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Rehabilitative orbital decompression treats disfiguring exophthalmos in patients with Graves' orbitopathy (GO). This study aimed to identify risk factors associated with the postoperative recurrence of proptosis after orbital decompression. DESIGN: Retrospective, case-control study. METHODS: This retrospective review included patients with GO who underwent rehabilitative orbital decompression for disfiguring proptosis in an inactive state with a low clinical activity score (0-2) between January 2017 and December 2020 by a single surgeon. Exophthalmos was measured using a Hertel exophthalmometer, and recurrence was defined as an increase of 2 mm or more after decompression during the follow-up period. The association between preoperative variables and proptosis recurrence was analyzed using multivariable logistic regression. RESULTS: Of the total 217 patients, 11 (5.1%) developed recurrence of proptosis during the follow-up period (range, 3-30; mean, 15.6 months). Univariate logistic regression analysis identified thyroid-stimulating hormone receptor antibody (TRAb) and thyroid-stimulating immunoglobulin (TSI) as significant factors for recurrence, with age, sex, smoking, disease duration, orbital radiotherapy, and total thyroidectomy history being nonsignificant. TRAb remained significant in a multivariate logistic regression analysis (odds ratio, 1.06; P = .014). Receiver operating characteristic curve analysis revealed an area under the curve of 0.86 with a sensitivity of 90.9% and specificity of 82.0% at a TRAb level of 7.96 IU/L. CONCLUSION: Preoperative TRAb and TSI are valuable markers to predict proptosis recurrence after orbital decompression. These results may help surgeons to decide the optimal timing for orbital decompression to lessen the risk of postoperative recurrence of proptosis.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Byeon HJ, Ko J, Kikkawa DO, et al. Preoperative Risk Factors for Proptosis Recurrence After Rehabilitative Orbital Decompression in Graves' Orbitopathy Patients. Am J Ophthalmol. 2023. PMID: 37544496. doi:10.1016/j.ajo.2023.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。